Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


Articles published in Cancer Cell

Retrieve available abstracts of 46 articles:
HTML format



Single Articles


    April 2021
  1. DRAPKIN BJ, Minna JD
    A rational targeted therapy for platinum-resistant small-cell lung cancer.
    Cancer Cell. 2021;39:453-456.
    PubMed     Abstract available


    February 2021
  2. FRESE KK, Simpson KL, Dive C
    Small cell lung cancer enters the era of precision medicine.
    Cancer Cell. 2021 Feb 6. pii: S1535-6108(21)00104.
    PubMed     Abstract available


    January 2021
  3. KUANG S, Leighl NB
    Lorlatinib in ALK-Rearranged Lung Cancer.
    Cancer Cell. 2021;39:25-27.
    PubMed     Abstract available


    October 2020
  4. LIANG W, Liu J, He J
    Driving the Improvement of Lung Cancer Prognosis.
    Cancer Cell. 2020;38:449-451.
    PubMed     Abstract available


  5. PRUIS MA, Hussain B, Bakker M, Hoek RAS, et al
    A Lung Cancer Patient with Dyspnea: Diagnostic Difficulties during the COVID-19 Pandemic.
    Cancer Cell. 2020 Oct 9. pii: S1535-6108(20)30499.
    PubMed    


    August 2020
  6. DEVARAKONDA S, Govindan R, Morgensztern D
    Mastering the Complex Targeted Therapy for Non-small Cell Lung Cancer.
    Cancer Cell. 2020 Aug 10. pii: S1535-6108(20)30372.
    PubMed     Abstract available


  7. DRAPKIN BJ, Minna JD
    Studying Lineage Plasticity One Cell at a Time.
    Cancer Cell. 2020;38:150-152.
    PubMed     Abstract available


  8. LAFAVE LM, Kartha VK, Ma S, Meli K, et al
    Epigenomic State Transitions Characterize Tumor Progression in Mouse Lung Adenocarcinoma.
    Cancer Cell. 2020;38:212-228.
    PubMed     Abstract available


    July 2020
  9. MARJANOVIC ND, Hofree M, Chan JE, Canner D, et al
    Emergence of a High-Plasticity Cell State during Lung Cancer Evolution.
    Cancer Cell. 2020 Jul 23. pii: S1535-6108(20)30316.
    PubMed     Abstract available


  10. NG J, Sutherland KD
    NOTCH Your Usual Suspect: MYC Charged with Controlling Neuroendocrine Cell-Fate in Small Cell Lung Cancer.
    Cancer Cell. 2020;38:17-20.
    PubMed     Abstract available


    June 2020
  11. SHEN Y, Wang X, Lu J, Salfenmoser M, et al
    Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer.
    Cancer Cell. 2020;37:800-817.
    PubMed     Abstract available


  12. YU X, Chan HTC, Fisher H, Penfold CA, et al
    Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity.
    Cancer Cell. 2020;37:850-866.
    PubMed     Abstract available


    May 2020
  13. IRELAND AS, Micinski AM, Kastner DW, Guo B, et al
    MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate.
    Cancer Cell. 2020 May 30. pii: S1535-6108(20)30218.
    PubMed     Abstract available


  14. COLES GL, Cristea S, Webber JT, Levin RS, et al
    Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells.
    Cancer Cell. 2020 May 22. pii: S1535-6108(20)30253.
    PubMed     Abstract available


  15. AUGERT A, Mathsyaraja H, Ibrahim AH, Freie B, et al
    MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer.
    Cancer Cell. 2020 May 13. pii: S1535-6108(20)30215.
    PubMed     Abstract available


  16. GUERRA SL, Maertens O, Kuzmickas R, De Raedt T, et al
    A Deregulated HOX Gene Axis Confers an Epigenetic Vulnerability in KRAS-Mutant Lung Cancers.
    Cancer Cell. 2020;37:705-719.
    PubMed     Abstract available


    March 2020
  17. ALAM H, Tang M, Maitituoheti M, Dhar SS, et al
    KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer.
    Cancer Cell. 2020 Mar 23. pii: S1535-6108(20)30106.
    PubMed     Abstract available


  18. BEDNAR F, Pasca di Magliano M
    Context-Dependent Immune Responses Explain Pancreatic Cancer Immunoresistance.
    Cancer Cell. 2020;37:261-263.
    PubMed     Abstract available


  19. LIU H, Kuang X, Zhang Y, Ye Y, et al
    ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis.
    Cancer Cell. 2020;37:324-339.
    PubMed     Abstract available


  20. HEGDE S, Krisnawan VE, Herzog BH, Zuo C, et al
    Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer.
    Cancer Cell. 2020;37:289-307.
    PubMed     Abstract available


    January 2020
  21. GOVEIA J, Rohlenova K, Taverna F, Treps L, et al
    An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates.
    Cancer Cell. 2020;37:21-36.
    PubMed     Abstract available


  22. KURPPA KJ, Liu Y, To C, Zhang T, et al
    Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.
    Cancer Cell. 2020;37:104-122.
    PubMed     Abstract available


    December 2019
  23. ZHANG H, Christensen CL, Dries R, Oser MG, et al
    CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer.
    Cancer Cell. 2019 Dec 9. pii: S1535-6108(19)30523.
    PubMed     Abstract available


    May 2019
  24. MORRIS LGT, Chan TA
    Lung Cancer Evolution: What's Immunity Got to Do with It?
    Cancer Cell. 2019;35:711-713.
    PubMed     Abstract available


    February 2019
  25. HELLMANN MD, Callahan MK, Awad MM, Calvo E, et al
    Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.
    Cancer Cell. 2019;35:329.
    PubMed    


    January 2019
  26. ORTIZ A, Gui J, Zahedi F, Yu P, et al
    An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles.
    Cancer Cell. 2019;35:33-45.
    PubMed     Abstract available


    December 2018
  27. LEE PC, Fang YF, Yamaguchi H, Wang WJ, et al
    Targeting PKCdelta as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer.
    Cancer Cell. 2018;34:954-969.
    PubMed     Abstract available


  28. SHEN M, Jiang YZ, Wei Y, Ell B, et al
    Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling.
    Cancer Cell. 2018 Dec 10. pii: S1535-6108(18)30537.
    PubMed     Abstract available


    July 2018
  29. FANG L, Teng H, Wang Y, Liao G, et al
    SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis.
    Cancer Cell. 2018;34:103-118.
    PubMed     Abstract available


  30. ZENG H, Jorapur A, Shain AH, Lang UE, et al
    Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.
    Cancer Cell. 2018;34:56-68.
    PubMed     Abstract available


    May 2018
  31. FRUH M, Peters S
    Genomic Features of Response to Combination Immunotherapy in Lung Cancer.
    Cancer Cell. 2018;33:791-793.
    PubMed     Abstract available


  32. LUKEY MJ, Katt WP, Cerione RA
    Targeting Therapy Resistance: When Glutamine Catabolism Becomes Essential.
    Cancer Cell. 2018;33:795-797.
    PubMed     Abstract available


  33. MOMCILOVIC M, Bailey ST, Lee JT, Fishbein MC, et al
    The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma.
    Cancer Cell. 2018;33:905-921.
    PubMed     Abstract available


    April 2018
  34. HELLMANN MD, Callahan MK, Awad MM, Calvo E, et al
    Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.
    Cancer Cell. 2018 Apr 21. pii: S1535-6108(18)30172.
    PubMed     Abstract available


  35. HELLMANN MD, Nathanson T, Rizvi H, Creelan BC, et al
    Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.
    Cancer Cell. 2018 Apr 12. pii: S1535-6108(18)30123.
    PubMed     Abstract available


    February 2018
  36. SANCLEMENTE M, Francoz S, Esteban-Burgos L, Bousquet-Mur E, et al
    c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling.
    Cancer Cell. 2018;33:217-228.
    PubMed     Abstract available


    January 2018
  37. GWINN DM, Lee AG, Briones-Martin-Del-Campo M, Conn CS, et al
    Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase.
    Cancer Cell. 2018;33:91-107.
    PubMed     Abstract available


    December 2017
  38. BERGER AH, Brooks AN, Wu X, Shrestha Y, et al
    High-throughput Phenotyping of Lung Cancer Somatic Mutations.
    Cancer Cell. 2017;32:884.
    PubMed    


    September 2017
  39. VAZ M, Hwang SY, Kagiampakis I, Phallen J, et al
    Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations.
    Cancer Cell. 2017;32:360-376.
    PubMed     Abstract available


  40. CLARK SJ, Molloy PL
    Smoke-Induced Changes to the Epigenome Provide Fertile Ground for Oncogenic Mutation.
    Cancer Cell. 2017;32:278-280.
    PubMed     Abstract available


    August 2017
  41. BEST MG, Sol N, In 't Veld SGJG, Vancura A, et al
    Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.
    Cancer Cell. 2017;32:238-252.
    PubMed     Abstract available


    April 2017
  42. SCHOENFELD JD, Sibenaller ZA, Mapuskar KA, Wagner BA, et al
    O2- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.
    Cancer Cell. 2017;31:487-500.
    PubMed     Abstract available


    March 2017
  43. WIELAND E, Rodriguez-Vita J, Liebler SS, Mogler C, et al
    Endothelial Notch1 Activity Facilitates Metastasis.
    Cancer Cell. 2017;31:355-367.
    PubMed     Abstract available


    February 2017
  44. JUSTILIEN V, Ali SA, Jamieson L, Yin N, et al
    Ect2-Dependent rRNA Synthesis Is Required for KRAS-TRP53-Driven Lung Adenocarcinoma.
    Cancer Cell. 2017;31:256-269.
    PubMed     Abstract available


  45. BERNS K, Berns A
    Awakening of "Schlafen11" to Tackle Chemotherapy Resistance in SCLC.
    Cancer Cell. 2017;31:169-171.
    PubMed     Abstract available


    May 2016
  46. BRADY JJ, Chuang CH, Greenside PG, Rogers ZN, et al
    An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency.
    Cancer Cell. 2016;29:697-710.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: